• PharmaCyte Biotech, Inc.
• 15 Dec, 2015

PharmaCyte Biotech is currently developing a treatment for Type 1 diabetes that is unique among available treatments for this disease. The Company's treatment will also be available for those who have Type 2 diabetes where traditional medications are no longer effective. PharmaCyte Biotech is developing a treatment that encapsulates a human cell line (Melligen cells) engineered to produce and store insulin.
Read more...